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Abstract Caveolin and caveolin containing rafts are
involved in the signaling of growth factors in various cell
types. Previous reports of our lab indicated a co-localiza-
tion of caveolin and the high afﬁnity nerve growth factor
(NGF) receptor tyrosine kinase A (TrkA). Mutual effects
have been observed among which a caveolin-1 knock-
down resulted in an impairment of the NGF signaling
cascade rather than in an increase of activity as expected
from other growth factor reports. On the other hand, an
over-expression of caveolin-1 impaired the NGF stimulated
activity of p42/44 mitogen activated protein kinases
(MAPK). In this study, we used a caveolin-1 scaffolding
domain (CSD) peptide (cavtratin) of which an inhibitory
effect on growth factor receptors was reported. Our data
showed that cavtratin suppresses the NGF-induced phos-
phorylation of TrkA as well as the activation of MAPK in
porcine oligodendrocytes signiﬁcantly.
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MAPK Mitogen-activated protein kinases
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Introduction
Neurotrophins constitute a family of six members which
include nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), and neurotrophin-3 (NT-3); they
are endogenously produced signaling molecules and play
an important role in a variety of cellular processes of neural
and non-neural cells (Levi-Montalcini et al. 1996; Althaus
and Richter-Landsberg 2000; Chao 2003; Vega et al.
2004). The initial step of the NGF signaling pathway via
TrkA is tyrosine phosphorylation (Heumann 1994) fol-
lowed by the activation of further downstream components
due to the association of other proteins to tyrosine phos-
phorylated sites of TrkA by their SH2 or PTB domains
(Pawson et al. 1993; Reichardt 2006).
Previous results had shown that oligodendrocytes (OL),
which myelinate axons in the central nervous system,
respond to NGF by inducing proliferation and enhancing
process regeneration (Althaus et al. 1992, 1997). They
contain caveolae-like ﬂask-shape structures to which the
high afﬁnity NGF-receptor TrkA was partially localized
(Schmitz et al. 2010). Caveolin serves as a structural
component of caveolae. It contains a scaffolding domain
(CSD) between amino acid 82 and 101 that facilitates an
interaction with different signaling molecules. This could
be shown by caveolin-1 mutants lacking a functional CSD
(Vihanto et al. 2006). In different cell models it has already
been shown that high levels of caveolin could inhibit signal
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with the generation of signaling complexes (Engelman
et al. 1998). Caveolin inhibits various signaling pathways
such as epidermal growth factor (EGF) (Couet et al. 1997;
Agelaki et al. 2009), Src family tyrosine kinases (Wanaski
et al. 2003) or platelet derived growth factor receptor
(Yamamoto et al. 1999) while the insulin receptor were
kept in an activated state (Burgermeister et al. 2008).
In this study, we have investigated the inﬂuence of CSD
on the TrkA/NGF signaling pathway in mature pig OL by
using a cell-permeable synthetic peptide (cavtratin) that
corresponds to the amino acids of the CSD. Our data
indicate that cavtratin inhibits the phosphorylation of TrkA
as well as the activity of downstream components of the
NGF signaling pathway such as MAPK Erk1 and 2. These
ﬁndings are relevant for a better understanding of the
regulation of the oligodendroglial process formation after
NGF and it may be of interest for the search for novel
suppressor proteins against glial tumors.
Materials and Methods
Reagents
All chemicals of analytical grade were obtained either
from Sigma–Aldrich (Taufkirchen, Germany) or Merck
(Darmstadt, Germany); culture media and fetal calf
serum were obtained from Biochrom (Berlin, Germany),
Mezlocillin from Bayer (Leverkusen, Germany). ECL
western blotting detection kit came from Amersham
(Freiburg, Germany).
Peptides
The short N-terminal cytoplasmic region of caveolin-1
located between amino acid 82 and 101 (DGIW-
KASFTTFTVTKYWFYR), known as the caveolin scaf-
folding domain (CSD) was synthesized as a fusion peptide
to the C-terminus of the Antennapedia internalization
sequence (RQIKIWFQNRRMKWKK) and termed as cav-
tratin (Calbiochem/Merck, Darmstadt, Germany). This
sequence of CSD exactly corresponds to the sequence of
Sus scrofa caveolin-1 at this position (Wang et al. 2008). A
scrambled peptide was used as a control (Calbiochem/
Merck, Darmstadt, Germany). Before use, the powder were
weighted and dissolved in DMSO to 10 mM and diluted to
1 mM with distilled water.
Cell Culture
OL were isolated from adult pig brain and cultivated on
poly-D-lysine-coated Petri dishes or multiwell cultured
plates by using an established protocol (Althaus et al. 1984;
Bu ¨rgisser et al. 1988; Althaus and Klo ¨ppner 2006). Brieﬂy,
the white matter of mature pig (domestic) brains was dis-
sected, minced, and sieved through nylon sieves of
descending pore size; cells were collected after centrifu-
gation of the cell tissue suspension onto a discontinuous
Percoll gradient; cells were seeded and cultured on poly-
D-lysine-coated Petri dishes or multiwall culture plates. The
culturing protocol was as previously described (Althaus
et al. 1991), except that the fetal calf serum in the culture
medium was reduced to 1–5%; TEM and immunocyto-
chemical criteria identiﬁed the cells as mature (GC
?,
MBP
?, PLP
?,M O C
?) OL (Althaus and Klo ¨ppner 2006;
Althaus et al. 1991; Althaus and Siepl 1997); A2B5
?,
GFAP
?, or OX4
2? cells were initially observed rarely if at
all (Althaus and Siepl 1997); anti-MOSP IgM (Chemicon,
Temecula, CA) diluted 1:1000 was routinely used to label
OL (Dyer and Matthieu 1994) in this study.
Immunocytochemistry
For immunocytochemical staining of phospho-TrkA (P-TrkA)
we used anti-P-TrkA IgG (Santa Cruz, Heidelberg,
Germany) diluted 1:100 and as secondary antibody Alexa
Fluor 488 goat anti-rabbit IgG (Molecular Probes/Invitro-
gen, Karlsruhe, Germany) diluted 1:1000. Moreover,
polyclonal anti-caveolin IgG (Transduction Laboratories,
Lexington, USA) diluted 1:1000 for western blot as well as
monoclonal anti-beta actin IgG (Abcam, Cambridge, UK)
diluted 1:10000 for western blot had been utilized.
After 8 DIV (days in vitro) under standard conditions,
OL were pre-treated with cavtratin (25 and 40 lM). After
1 h incubation, NGF (100 ng/ml) was added into the cell
medium. Under the same conditions OL were treated with
a scrambled (non-sense) peptide.
For staining of P-TrkA OL were pre-treated with 1 mM
sodium orthovanadate for 1 h, washed with PBS (con-
taining a mixture of protease inhibitors: 1 mM sodium
orthovanadate, 1 mM sodium ﬂuoride, 1 mM phenyl-
methylsulfonyl ﬂuoride, 1 lg/ml aprotinin, and 1 lg/ml
leupeptide). Afterwards, cells were ﬁxed in methanol/ace-
tic acid (9:1) and treated with 0.1% Triton X-100. The
antibody incubation for the P-TrkA-staining took around
1 h at room temperature by smooth shaking.
Western Blotting
OL were pre-treated with 1 mM sodium orthovanadate for
1 h, washed with PBS (phosphate buffered saline) con-
taining a mixture of inhibitors (1 mM sodium orthovana-
date, 1 mM sodium ﬂuoride, 1 mM phenylmethylsulfonyl
ﬂuoride, 1 lg/ml aprotinin, and 1 lg/ml leupeptide) and
harvested by scraping on ice. The cells were lysed in 2%
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123SDS, containing all inhibitors, for 30 min, denaturated in
sample buffer (containing mercaptoethanol), and heated at
95C for 2 min.
Protein samples of equivalent protein content (20 lg/ml;
protein determination according to Neuhoff et al. 1979)
were separated by 10–15% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) according to
Laemmli (1970) and transferred to polyvinylidene diﬂuo-
ride (PVDF) membranes (Amersham). PVDF membranes
were blocked with 5% dried milk in PBS and 0.1% Tween-
20 for 1 h at room temperature, and afterwards probed with
the antibodies of interest overnight at 4C. ECL anti-rabbit
IgG from Amersham (diluted 1:1000) was utilized as sec-
ondary antibody. The bands were visualized by the
enhanced chemiluminescence (ECL) detection system
according to the manufacturer’s instructions.
Caveolin-1 Over-Expression
Previous results had shown that the level of caveolin-1 was
up-regulated after stimulation of OL with NGF (100 ng/ml)
for 48 h (Schmitz et al. 2010). To analyse the effect of
caveolin-1 on the activity of MAPK (Erk and Erk2), 8 DIV
OL were pre-incubated with NGF (100 ng/ml). After 48 h
the medium was removed, cells were washed three times
in PBS and incubated in fresh medium for 12 h under
standard conditions. Afterwards the cells were incubated
with NGF (100 ng/ml) for 4 h and the activity of MAPK
(Erk1 and 2) were examined in an in-gel kinase assay in
comparison to OL stimulated with NGF for 4 h without
NGF pre-treatment.
In-Gel MAPK Assay
OL were exposed to NGF for the times indicated. The cell
lysates were separated by SDS-PAGE using a gel in which
10% MBP (myelin basic protein) was incorporated. The
renatured MAPK (Erk1 and Erk2) activity was detected
following a modiﬁed protocol (Althaus et al., 1997)o f
Virdee and Tolkovsky (1995). The gel was incubated in an
assay buffer for 60 min at 30C allowing the transfer of
radioactive phosphor to myelin basic protein. Not incor-
porated radioactivity was removed by washing the gel
several times in 5% TCA (trichloroacetic acid) containing
1% (w/v) tetrasodium pyrophosphate. Afterwards the gel
was dried overnight and subjected to autoradiography at
-70C, using an RX-Fuji X-ray ﬁlm.
Statistics
The quantiﬁcation of the signal intensities of all western
blots was performed by Scion Image. Using the statistic
program Graph Pad Prism 4 and the Student’s t test the
ratios of different samples were tested for signiﬁcance. All
P values below 0.05 are considered as signiﬁcant (*); under
0.01 as highly signiﬁcant (**). The standard deviation (SD)
was calculated to assess the variations between different
samples under the same conditions and depicted as error
Fig. 1 Inhibition of MAPK activity after caveolin-1 up-regulation.
OL, exposed to NGF for 48 h, revealed a signiﬁcant up-regulation of
caveolin-1 expression (P\0.01) compared to untreated control cells
and cells which were exposed to NGF for 4 or 24 h. An MAPK in-gel
kinase assay showed that OL, pre-treated with NGF for 48 h, revealed
a signiﬁcant reduced activity of MAPK after 4 h NGF-incubation in
comparison to cells, pre-incubated with NGF for 24 h or for 4 h
solely. Untreated OL revealed a basal activity of MAPK. b-Actin was
used as an internal control showing that equal amounts of protein had
been loaded on the gel. For evaluation protein bands were quantiﬁed
by Scion Image; control cells were set as 100%; data represent the
average of three independent assays ± SD (standard deviation),
calculated by Graph Pad Prism; when *P\0.05 (student’s t test) the
data were considered as signiﬁcant
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independent attempts.
Results
Caveolin-1 Over-Expression After NGF Exposure
Inhibited the Activity of MAPK
Previous publications had shown that NGF stimulates the
oligodendroglial process formation by activating MAPK
(Erk1 and 2) (Althaus et al. 1992, 1997). In this context, we
observed an approximately twofold up-regulation of
caveolin-1 expression in OL treated with NGF for 48 h
compared to OL treated with NGF for 4 and 24 h or
untreated OL (Fig. 1). We used this model to examine the
MAPK activity in OL with an enhanced caveolin-1
expression in an in-gel kinase assay. OL were pre-incu-
bated with NGF for 24 and 48 h. After 12 h under standard
conditions, cells were incubated with NGF for 4 h and the
activity of MAPK (Erk1 and 2) were examined in an in-gel
kinase assay. Interestingly, OL pre-incubated with NGF for
48 h revealed a signiﬁcant decrease of approximately 50%
of MAPK activity (P\0.05) after 4 h NGF exposure
compared to OL pre-incubated with NGF for 24 h or
treated with NGF for 4 h solely. Non-NGF treated control
cells, showing a basal activity of MAPK, were set as 100%
(Fig. 1).
Effect of Cavtratin on the TrkA Phosphorylation
Via NGF
NGF induces a TrkA dimerization with subsequent tyrosine
phosphorylation via its intrinsic tyrosine kinase activity
(Reichardt 2006), a required step for the formation of oli-
godendroglial processes. Here, we investigated the effect
of cavtratin on the phosphorylation of TrkA in pig OL
before and after NGF stimulation. Without NGF addition,
only few cells expressed phosphorylated TrkA (P-TrkA) as
shown immunocytochemically and via western blotting
(Figs. 2a3, 3a1).
Cells pre-incubated with the cell-permeable CSD pep-
tide cavtratin (40 lM) revealed up to 40% reduced level of
P-TrkA after exposure to NGF (Figs. 2a2, 3a3); whereas an
increase of P-TrkA could be observed in OL treated with a
scrambled peptide that are exposed to NGF for 1 h
(Figs. 2a1, 3a2).
Inﬂuence of Cavtratin on the Activity of NGF
Downstream Components Erk1 and Erk2 (MAPK)
Downstream components of the NGF signaling cascade
such as the MAPK (Erk1 and Erk2), of which previous
results had shown that oligodendroglial process regenera-
tion depends on their activity (Althaus and Richter-
Landsberg 2000).
OL, cultured for 8 DIV were pre-incubated with
cavtratin and with a scrambled peptide for 1 h. After
NGF treatment, OL pre-incubated with a scrambled
peptide (Fig. 3b3) responded with an increased MAPK
activity almost similarly to non-pre-incubated cells
(Fig. 3b4). In contrast, OL pre-incubated with cavtratin
responded to NGF with a signiﬁcant decrease (*60%) of
MAPK activity (P\0.01) (Fig. 3b5 and 6). Without
NGF stimulation, oligodendroglial MAPK activity
remained at a basal level independent of cavtratin addi-
tion (Fig. 3b1, 2).
Fig. 2 Inhibition of the NGF-induced phosphorylation of TrkA via
cavtratin. A few OL exhibit P-TrkA under standard conditions
without NGF when labeled immunocytochemically with a rabbit
polyclonal anti-phospho-TrkA IgG and an Alexa Fluor 488 conju-
gated second antibody (a3). Exposure to NGF (100 ng/ml) for 1 h,
induced phosphorylation of TrkA in cells pre-treated with a scram-
bled peptide (a1), whereas pre-incubation with cavtratin (40 lM) for
1 h reduced TrkA phosphorylation signiﬁcantly after NGF stimula-
tion (P\0.05) (a2). b The proportion of ﬂuorescent cells versus non-
ﬂuorescent cells was determined. For evaluation the amount of
ﬂuorescent cells was calculated in % of total cells; data represent the
average of three independent experiments ± SD, calculated by Graph
Pad Prism; when *P\0.05 (student’s t test) the data were
considered as signiﬁcant
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Porcine OL contain caveolin containing rafts (CCRs) in
their plasma membranes and express caveolin-1 (Schmitz
et al. 2010; Althaus et al. 2008). Several studies on other
cell types had provided evidence that caveolin may exert
an inhibitory inﬂuence on signaling pathways (Couet et al.
1997), reduces inﬂammation (Bucci et al. 2000) and sup-
presses the progression of tumors (Gratton et al. 2003;
Williams and Lisanti 2005). A short N-terminal cytoplas-
mic region of caveolin-1 located between amino acid 82
and 101, known as the CSD (Wanaski et al. 2003), appears
to exert a nonselective, universal kinase inhibition (Couet
et al. 1997; Liu et al. 2002) essential for the down regu-
lation of signaling cascades (Razani and Lisanti 2001).
Receptor tyrosine kinases such as EGFR (epidermal growth
factor receptor) (Couet et al. 1997) or PDGFR (platelet
derived growth factor receptor) (Yamamoto et al. 1999) are
known targets which may be negatively regulated by CSD
(Williams and Lisanti 2005); however, a CSD interaction
with TrkA has not yet been shown. In case of pig OL
caveolin-1 has been found in the oligodendroglial plasma
membrane, where it was co-localized with signaling com-
ponents of the NGF signaling cascade such as TrkA,
P-TrkA, and MAPK (Althaus et al. 1992). Surprisingly, a
knock-down of caveolin-1 resulted in a reduced rather than
in an enhanced activity of these components. On the other
hand, an increased up-regulation of caveolin-1 inhibited
MAPK activity. These results seem to indicate that a bal-
ance of a caveolin level is important for regulating cellular
signaling: a certain caveolin-1 level is required to keep the
signaling of caveolin containing platforms in an optimal
condition, whereas an increased caveolin-1 level counter-
acts signaling (Czarny et al. 1999). In this context we have
asked the question could not only MAPK but also TrkA be
inhibited by CSD directly. Our results revealed an inhibi-
tory effect of cavtratin on the activity of p42/44 MAPK; a
sustained reduced MAPK activity could impair the oligo-
dendroglial process formation after NGF as previously
shown (Schmitz et al. 2010). Other studies had already
shown that the inhibitory activity of CSD is not limited to
tyrosine kinases. It inhibits also serine/threonine kinases
(Couet et al. 1997). These observations are consistent with
previous in vitro and in vivo studies demonstrating that
caveolin negatively regulates the p42/p44 MAPK by
directly binding to catalytic domains of these kinases
through the CSD (Engelman et al. 1998; Bianco et al.
2008). However, whether caveolin interacts with p42/44
MAPK and/or with a component upstream of MAPK has
not yet been proven. Pig OL exposed to cavtratin revealed
a decreased phosphorylation of TrkA after NGF treatment.
Hence, TrkA appears to belong to the category of signal
molecules which directly interact with the CSD (Bianco
et al. 2008). These results may also be relevant for human
Fig. 3 Detection and quantiﬁcation of P-TrkA and MAPK (Erk1 and
2) after cavtratin treatment and NGF. a The phosphorylation of TrkA
was determined by western blotting using anti-phospho-TrkA IgG. A
treatment with NGF (100 ng/ml) for 1 h induced phosphorylation of
TrkA in cells, pre-treated with a scrambled peptide (a2). Pre-
incubation with cavtratin for 1 h reduced TrkA phosphorylation
signiﬁcantly (P\0.05) (a3). Untreated cells showed a basal level of
TrkA phosphorylation (a1). b Cavtratin treated OL were examined for
Erk1/Erk2 activity in an in-gel kinase assay. After NGF exposure for
2 h (100 ng/ml), the MAPK activity of cavtratin pre-treated OL was
signiﬁcantly decreased (P\0.01) (b5 cavtratin 25 lM and b6
cavtratin 40 lM), compared to cells, pre-incubated with a scrambled
peptide (b3) and non-pretreated OL (b4). The MAPK activity of cells
treated with cavtratin (40 lM) without NGF (b2) was comparable to
that of untreated control cells (a1) which was set as 100% for the gray
scale quantiﬁcation. For gray scale evaluation protein bands were
quantiﬁed by Scion Image; data represent the average of three
independent assays ± SD, calculated by Graph Pad Prism; when
*P\0.05 (student’s t test) the data were considered as signiﬁcant
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and human Trk/caveolin; in addition, TrkA is expressed in
human OL (Althaus et al. 2001).
Furthermore, our ﬁndings that cavtratin reduced the
activity of a glial growth factor signaling cascade, which
promotes proliferation and process formation in OL, may
be of interest not only in terms of myelination but it may
also be relevant for interfering with glial tumors. Previous
experiments on other cell types have suggested that a
caveolin/cavtratin based treatment inhibits tumor growth
(Gratton et al. 2003). In this respect the CSD of caveolin
may also be considered as a novel therapeutic approach in
glial pathology. The inﬂuence of cavtratin on the growth
and differentiation of glioblastoma cells is currently under
investigation.
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